136 related articles for article (PubMed ID: 11152776)
21. Can a multiphasic contrast-enhanced three-dimensional fast spoiled gradient-recalled echo sequence be sufficient for liver MR imaging?
Coulam CH; Chan FP; Li KC
AJR Am J Roentgenol; 2002 Feb; 178(2):335-41. PubMed ID: 11804888
[TBL] [Abstract][Full Text] [Related]
22. Conspicuity of liver hemangiomas: short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid.
Brody JM; Schafer L; Tung GA; Breuer J; Shamsi K
J Magn Reson Imaging; 2005 Apr; 21(4):391-7. PubMed ID: 15778951
[TBL] [Abstract][Full Text] [Related]
23. Hepatic lesions: morphologic and functional characterization with multiphase breath-hold 3D gadolinium-enhanced MR angiography--initial results.
Hawighorst H; Schoenberg SO; Knopp MV; Essig M; Miltner P; van Kaick G
Radiology; 1999 Jan; 210(1):89-96. PubMed ID: 9885592
[TBL] [Abstract][Full Text] [Related]
24. Current uses of gadolinium chelates for clinical magnetic resonance imaging examination of the liver.
Low RN
Top Magn Reson Imaging; 1998 Jun; 9(3):141-66. PubMed ID: 9621404
[TBL] [Abstract][Full Text] [Related]
25. Liver MRI in the hepatocyte phase with gadolinium-EOB-DTPA: does increasing the flip angle improve conspicuity and detection rate of hypointense lesions?
Bashir MR; Husarik DB; Ziemlewicz TJ; Gupta RT; Boll DT; Merkle EM
J Magn Reson Imaging; 2012 Mar; 35(3):611-6. PubMed ID: 22034383
[TBL] [Abstract][Full Text] [Related]
26. Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA)--preliminary results of phase II clinical application.
Caudana R; Morana G; Pirovano GP; Nicoli N; Portuese A; Spinazzi A; Di Rito R; Pistolesi GF
Radiology; 1996 May; 199(2):513-20. PubMed ID: 8668804
[TBL] [Abstract][Full Text] [Related]
27. MR imaging of the liver using gadolinium chelates.
Low RN
Magn Reson Imaging Clin N Am; 2001 Nov; 9(4):717-43, vi. PubMed ID: 11694435
[TBL] [Abstract][Full Text] [Related]
28. [Status and development of new clinical contrast media for MR diagnosis of liver diseases].
Rummeny EJ; Peters PE
Radiologe; 1992 May; 32(5):225-31. PubMed ID: 1635982
[TBL] [Abstract][Full Text] [Related]
29. Contrast agents for MR imaging of the liver.
Low RN
J Magn Reson Imaging; 1997; 7(1):56-67. PubMed ID: 9039594
[TBL] [Abstract][Full Text] [Related]
30. Magnetic resonance imaging features of common focal liver lesions in children.
Masand PM
Pediatr Radiol; 2018 Aug; 48(9):1234-1244. PubMed ID: 30078045
[TBL] [Abstract][Full Text] [Related]
31. Contrast material for computed tomography and magnetic resonance imaging of the gastrointestinal tract.
Hamm B; Wolf KJ
Curr Opin Radiol; 1991 Jun; 3(3):474-82. PubMed ID: 1859783
[TBL] [Abstract][Full Text] [Related]
32. Hepatocyte-specific contrast media for CT. An experimental investigation.
Bergman A
Acta Radiol Suppl; 1997; 411():1-27. PubMed ID: 9164354
[TBL] [Abstract][Full Text] [Related]
33. Gaucher disease in the liver on hepatocyte specific contrast agent enhanced MR imaging.
Ayyala RS; Teot LA; Perez Rossello JM
Pediatr Radiol; 2017 Apr; 47(4):484-487. PubMed ID: 28144704
[TBL] [Abstract][Full Text] [Related]
34. MR imaging of diffuse liver disease: from technique to diagnosis.
Hope TA; Ohliger MA; Qayyum A
Radiol Clin North Am; 2014 Jul; 52(4):709-24. PubMed ID: 24889168
[TBL] [Abstract][Full Text] [Related]
35. Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions.
Ba-Ssalamah A; Uffmann M; Saini S; Bastati N; Herold C; Schima W
Eur Radiol; 2009 Feb; 19(2):342-57. PubMed ID: 18810454
[TBL] [Abstract][Full Text] [Related]
36. Hepatocyte-specific contrast media: not so simple.
Trout AT; Towbin AJ; Smith EA; Gupta A; Dillman JR
Pediatr Radiol; 2018 Aug; 48(9):1245-1255. PubMed ID: 30078050
[TBL] [Abstract][Full Text] [Related]
37. Contrast-enhanced magnetic resonance imaging of the liver.
Van Beers B
J Belge Radiol; 1997 Dec; 80(6):322. PubMed ID: 9479919
[No Abstract] [Full Text] [Related]
38. Contrast agents for MR imaging of the liver: a clinical overview.
Mahfouz AE; Hamm B; Taupitz M
Eur Radiol; 1997; 7(4):507-13. PubMed ID: 9204329
[TBL] [Abstract][Full Text] [Related]
39. CT and MR perfusion techniques to assess diffuse liver disease.
Ronot M; Leporq B; Van Beers BE; Vilgrain V
Abdom Radiol (NY); 2020 Nov; 45(11):3496-3506. PubMed ID: 31768595
[TBL] [Abstract][Full Text] [Related]
40. MR imaging techniques of the liver.
Siegelman ES; Outwater EK
Radiol Clin North Am; 1998 Mar; 36(2):263-86. PubMed ID: 9520981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
